Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LINDIG U")

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 4 of 4

  • Page / 1

Export

Selection :

  • and

ZUM TRANSPORTVERHALTEN NIEDERER KOHLENWASSERSTOFFE IN 4A-ZEOLITHEN - EIN NEUER MOLEKULARSIEBEFFEKT = ON THE TRANSPORT BEHAVIOUR OF LOW OLEFINS IN 4A ZEOLITES - A NEW MOLECULAR SIEVE EFFECT = SUR LE MECANISME DU TRANSPORT D'HYDROCARBURES LEGERS DANS DES ZEOLITES 4A. UN EFFET NOUVEAU EN TAMIS MOLECULAIRESCHOELLNER R; MUELLER U; NOETZEL P et al.1981; WISS. Z. KARL-MARX-UNIV. LEIPZIG, MATH.-NAT. WISS. REIHE; ISSN 500135; DDR; DA. 1981; VOL. 30; NO 4; PP. 388-396; BIBL. 16 REF.Article

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma : a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)WAGNER, A. D; BUECHNER-STEUDEL, P; WEIN, A et al.Annals of oncology. 2007, Vol 18, Num 1, pp 82-87, issn 0923-7534, 6 p.Article

Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)FENSTERER, H; SCHADE-BRITTINGER, C; KORNMANN, M et al.Annals of oncology. 2013, Vol 24, Num 10, pp 2576-2581, issn 0923-7534, 6 p.Article

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeMOEHLER, M; MADERER, A; SCHÜTZ, M et al.European journal of cancer (1990). 2014, Vol 50, Num 18, pp 3125-3135, issn 0959-8049, 11 p.Article

  • Page / 1